View in EDS HTML Full Text PDF Full Text

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Saved in:
Bibliographic Details
Title: Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.
Authors: Banegas, Daniela Estefania1 (AUTHOR), Ferrarini, Isacco1 (AUTHOR), Bernardelli, Andrea1 (AUTHOR), Moioli, Alessia1 (AUTHOR), Zilioli, Vittorio Ruggero2 (AUTHOR), Nassi, Luca3 (AUTHOR), Rusconi, Chiara4 (AUTHOR), Casadei, Beatrice5 (AUTHOR), Pellegrini, Cinzia5,6 (AUTHOR), Gini, Guido7 (AUTHOR), Gritti, Giuseppe8 (AUTHOR), Daghia, Giulia9 (AUTHOR), Pennese, Elsa10 (AUTHOR), Petrucci, Luigi11 (AUTHOR), Ferrero, Simone12 (AUTHOR), De Lorenzo, Sonya13 (AUTHOR), Usai, Sara Veronica14 (AUTHOR), Gorgone, Ausilia15 (AUTHOR), Gentile, Massimo16,17 (AUTHOR), Castellino, Alessia18 (AUTHOR)
Source: Leukemia & Lymphoma. May2026, Vol. 67 Issue 6, p1414-1418. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2621825